Results of aortic valve repair using decellularized bovine pericardium in congenital surgery
- 1 December 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 54 (6), 986-992
- https://doi.org/10.1093/ejcts/ezy181
Abstract
OBJECTIVES: The search for an optimal patch material for aortic valve reconstruction (AVR) is an ongoing challenge. In this study, we report our experience of AVR using decellularized bovine pericardial patch material in congenital heart surgery. METHODS: Data of 40 consecutive patients who underwent AVR using the CardioCel (R) patch (Admedus Regen Pty Ltd, Perth, WA, Australia) between February 2014 and August 2016 were retrospectively reviewed. The median age of the patients at operation was 9 (2-34) years, and 18 patients were younger than 7 years. Twenty-six patients initially presented with aortic valve insufficiency (AI) and 14 with stenosis. Clinical and echocardiographic data were available until August 2017 for a median postoperative follow-up (FU) of 22 (6-42) months. RESULTS: Nine of 40 (23%) patients experienced an event during FU (death: n = 1, 2.5%; reoperation: n = 8, 20%). Overall, the probability of freedom from reoperation or death was 97 +/- 3%, 76 +/- 9% and 57 +/- 12% at 12, 24 and 36 months of FU, respectively. Reason for reoperation was stenosis in 3 (37.5%) patients, insufficiency in 4 (50%) patients and 1 (12.5%) patient was diagnosed with aortic valve endocarditis. Of the remaining 31 patients, 2 patients are scheduled for reoperation (aortic valve stenosis: n = 1 and AI: n = 1) and 9 patients exhibit worsening of aortic valve function with moderate AI. Freedom from developing combined end point [death/reoperation/moderate degree of aortic valve dysfunction (aortic valve stenosis, AI)] after AVR was 92 +/- 5%, 55 +/- 9% and 28 +/- 9% at 12, 24 and 36 months, respectively. CONCLUSIONS: AVR using decellularized bovine pericardial patch material in patients with congenital aortic valve disease show unsatisfactory results within the first 3 years of FU.This publication has 15 references indexed in Scilit:
- Biostability, durability and calcification of cryopreserved human pericardium after rapid glutaraldehyde-stabilization versus multistep ADAPT(R) treatment in a subcutaneous rat modelEuropean Journal of Cardio-Thoracic Surgery, 2014
- Surgical Valvotomy and Repair for Neonatal and Infant Congenital Aortic Stenosis Achieves Better Results Than Interventional CatheterizationJournal of the American College of Cardiology, 2013
- Evaluation of a tissue-engineered bovine pericardial patch in paediatric patients with congenital cardiac anomalies: initial experience with the ADAPT-treated CardioCel(R) patchInteractive CardioVascular and Thoracic Surgery, 2013
- Long-term results of a strategy of aortic valve repair in the pediatric populationThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Aortic cusp extension valvuloplasty with or without tricuspidization in children and adolescents: Long-term results and freedom from aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Aortic valve repair leads to a low incidence of valve-related complicationsEuropean Journal of Cardio-Thoracic Surgery, 2010
- Ross operation: 16-year experienceThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Surgical strategy for the bicuspid aortic valve: Tricuspidization with cusp extension versus pulmonary autograftThe Journal of Thoracic and Cardiovascular Surgery, 2007
- The Relationship Between Neo-Aortic Root Dilation, Insufficiency, and Reintervention Following the Ross Procedure in Infants, Children, and Young AdultsJournal of the American College of Cardiology, 2007
- Up to 16 years follow-up of aortic valve reconstruction with pericardium: a stentless readily available cheap valve?☆European Journal of Cardio-Thoracic Surgery, 2005